US Organ Preservation Market Size, Share,Trends, Growth Analysis Report, 2030

Overview Request Sample Pages Request Customization Download PDF

You are viewing: US Organ Preservation Market analysis

Part of: Organ Preservation Market (Global)

The US Organ Preservation Market was valued at $79.77 Million in 2025 and projected to reach to $112.99 Million by 2030, representing a compound annual growth rate of 7.2%. The US organ preservation market is poised for sustained growth through 2030, driven by increasing transplant volumes and healthcare system modernization.

US Organ Preservation Market Trends and Insights

This expansion reflects the US healthcare system's increasing investment in advanced preservation technologies to improve transplant outcomes and reduce organ wastage.
The US market is driven by rising demand for organ transplantation, technological innovations in preservation solutions, and growing awareness of the critical need for viable donor organs. In the US, the organ preservation sector is characterized by significant clinical adoption of both static cold storage and machine perfusion technologies.
The US market's 7.2% compound annual growth rate outpaces global trends, indicating strong regional momentum.
Between 2025 and 2030, the US is expected to see accelerated deployment of next-generation preservation systems in major transplant centers, supported by favorable reimbursement policies and regulatory frameworks that encourage innovation in the US healthcare landscape..

Key Market Statistics

CAGR (2025-2030) 7.2% CAGR
Market Size, 2025 ~USD 79.77 Million
Forecast, 2030 ~USD 112.99 Million
Country US

US Organ Preservation Market Overview

Market Valuation :

The US organ preservation market is valued at $79.77 million in 2025, with strong growth trajectory reaching $112.99 million by 2030, representing a 7.2% CAGR.

Healthcare Investment :

US healthcare institutions are significantly investing in advanced organ preservation technologies to improve transplant success rates and minimize organ wastage across major medical centers.

Transplant Demand Growth :

Rising demand for organ transplantation in the US is driving adoption of preservation solutions, with hospitals prioritizing technologies that extend organ viability and improve patient outcomes.

Technological Innovation :

The US market is characterized by rapid advancement in preservation techniques, including machine perfusion systems and novel preservation solutions developed by leading medical device manufacturers.

US Organ Preservation Market Dynamics

Hospitals and transplant centers are prioritizing advanced preservation technologies to address the critical shortage of viable organs and improve transplant success rates.
Regulatory support and reimbursement improvements are facilitating market expansion.
The competitive landscape features both established medical device companies and innovative startups developing next-generation preservation solutions.
Investment in research and development continues to enhance preservation efficacy, positioning the US market as a leader in transplant technology adoption and innovation..

Related Ecosystem

Medical Devices

Top Technologies

Polymerase Chain Reaction (PCR)
Magnetic Resonance Imaging (MRI)
Disposable Autoinjectors
Pulse Oximeters
Blood Pressure Monitors

Top Companies

Medtronic plc
Abbott Laboratories
Stryker Corporation
Becton, Dickinson and Company
JOHNSON & JOHNSON

Key Takeaways

The US organ preservation market is valued at $79.77 million in 2025 and will reach $112.99 million by 2030, representing a 7.2% CAGR.
The US market growth is driven by increasing organ transplant demand, technological advancements, and improved reimbursement policies specific to the US healthcare system.
Machine perfusion technology adoption is accelerating in the US, offering superior outcomes compared to traditional static cold storage methods.
The US regulatory environment and strong healthcare infrastructure position the country as a leader in organ preservation innovation and market expansion.

Organ Preservation Market Report Scope

Report Metric	Details
Base Year	2025
Fastest Growing Segment	PERFADEX (Solution)
Forecast Period	2025�2030
Growth Rate	CAGR of 6.8% from 2025 to 2030
Largest Segment	ORGAN TRANSPLANT CENTERS (End User)
Market Size Base Year (Billions)	~USD 0.22 (2025)
Revenue Forecast (Billions)	~USD 0.3 (2030)
Segments Covered	Solution, Technique, Organ Type, End User

US Organ Preservation Market Report Segmentation

4 segment dimensions are covered across the global market.

By Solution

Custodiol Htk
Other Solutions
Perfadex
University Of Wisconsin Solution

By Technique

Hypothermic Machine Perfusion
Normothermic Machine Perfusion
Static Cold Storage

By Organ Type

Heart
Kidneys
Liver
Lungs
Other Organs

By End User

Hospitals
Organ Transplant Centers
Specialty Clinics

Target Audience

Medical Device Manufacturers : Manufacturers need US-specific market data to develop competitive organ preservation products, understand regulatory pathways, and identify distribution opportunities in American healthcare systems.
Hospital & Transplant Centers : Transplant facilities require market intelligence to evaluate preservation technology investments, benchmark against peers, and optimize organ utilization rates and patient outcomes.
Healthcare Investors & PE Firms : Investment professionals need comprehensive US market analysis to identify acquisition targets, assess growth potential, and make informed funding decisions in the organ preservation sector.
Pharmaceutical & Biotech Companies : Companies developing preservation solutions need US market insights to guide R&D investments, clinical trial planning, and commercialization strategies for American markets.
Healthcare Consultants & Advisors : Consultants require detailed US market data to advise clients on technology adoption, competitive positioning, and strategic initiatives in organ transplantation and preservation.

Key Companies in the US Organ Preservation Market

Company	HQ	Ownership	Strongest segments
KINDRED HEALTHCARE INC.	United States	Private Company	Static Cold Storage�linked care (all solutions),Hypothermic machine perfusion�linked care,Normothermic perfusion�linked care,
XVIVO PERFUSION AB	Sweden	Public Company	Perfadex Plus and lung preservation solutions (incl. STEEN Solution),XPS EVLP systems, lung kits, organ chambers, cannula sets,Kidney Assist (Transport and multi-mode) platforms and related solutions,
TRANSMEDICS, INC.	United States	Public Company	OCS Heart,OCS Lung,OCS Liver,
BIOLIFE SOLUTIONS, INC.	United States	Public Company	HypoThermosol FRS (hypothermic preservation media),CryoStor Freeze Media,evo Shipping Containers (cold-chain transport),
SHANGHAI GENEXT MEDICAL TECHNOLOGY CO., LTD.	China	Private Company	UW and Custodial HTK-equivalent preservation solutions,Perfadex-type and lung/heart-focused perfusion solutions,Preservation and transport devices (static cold storage, hypothermic, normothermic platforms),

KINDRED HEALTHCARE INC.

Kindred Healthcare Inc. is a United States-based private company founded in 1985 that operates as a major healthcare services provider with 64,200 employees.

XVIVO PERFUSION AB

XVIVO Perfusion AB is a Swedish public company founded in 1998 with 199 employees operating in the medical device and perfusion technology sector.

TRANSMEDICS, INC.

TransMedics, Inc. is a United States-based public company founded in 1998 with 898 employees specializing in organ preservation and transplant technology.

BIOLIFE SOLUTIONS, INC.

BioLife Solutions, Inc. is a United States-based public company founded in 1987 with 155 employees providing biopreservation solutions for cell and tissue therapies.

SHANGHAI GENEXT MEDICAL TECHNOLOGY CO., LTD.

Shanghai Genext Medical Technology Co., Ltd. is a Chinese private company founded in 2004 with 62 employees specializing in medical technology development.

Reasons to Buy this Report

Market Size & Growth Data : Access precise US market valuation ($79.77M in 2025) and 5-year forecast projections with 7.2% CAGR to support strategic planning and investment decisions.
Competitive Landscape Intelligence : Understand the US competitive environment, identify key players in organ preservation technology, and analyze market positioning strategies specific to American healthcare systems.
Regulatory & Reimbursement Insights : Gain detailed knowledge of US FDA regulations, Medicare/insurance reimbursement policies, and healthcare compliance requirements affecting organ preservation adoption.
Technology Adoption Trends : Identify emerging preservation technologies gaining traction in US hospitals, transplant centers, and research institutions to inform product development and market entry strategies.
Strategic Growth Opportunities : Discover high-potential segments within the US market, geographic hotspots for expansion, and partnership opportunities with leading transplant centers and healthcare networks.

Frequently asked questions

What is the current size of the US organ preservation market?

The US organ preservation market is valued at $79.77 million in 2025 and is projected to grow to $112.99 million by 2030.

What is the growth rate of the US organ preservation market?

The US organ preservation market is growing at a compound annual growth rate (CAGR) of 7.2% from 2025 to 2030.

What factors are driving growth in the US organ preservation market?

Key drivers include rising demand for organ transplantation in the US, technological innovations in preservation solutions, improved reimbursement policies, and increased awareness of organ shortage challenges.

Which technologies are most prevalent in the US organ preservation market?

The US market utilizes both static cold storage and machine perfusion technologies, with increasing adoption of advanced machine perfusion systems for superior organ viability.

How does the US organ preservation market compare to global trends?

The US market's 7.2% CAGR outpaces the global average of 6.8%, reflecting stronger regional demand and favorable healthcare infrastructure in the US.

RESEARCH METHODOLOGY

The study involved four major activities to estimate the current size of the organ preservation market—exhaustive secondary research collected information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, market breakdown and data triangulation procedures were used to estimate the market size of the segments and subsegments.

Secondary Research

In the secondary research process, various sources were utilized to identify and gather information to study the organ preservation market. These sources included company annual reports, press releases, investor presentations, white papers, certified publications, and articles by recognized authors. We also consulted reputable websites, regulatory bodies, and databases such as D&B Hoovers, Bloomberg Business, and Factiva.

This research aimed to gather crucial information about the leading companies in the industry, market classification, and segmentation based on industry trends down to the most detailed levels, including geographic markets. Additionally, we focused on key developments related to the market. Through this secondary research, a database of key industry leaders was created.

Primary Research

Extensive primary research was conducted after gathering information about the organ preservation market through secondary research. Several primary interviews were held with market experts from both the demand and supply sides across major regions, including North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. Data was collected through questionnaires, emails, and telephone interviews. The primary sources from the supply side included various industry experts, such as Chief Executive Officers (CEOs), Vice Presidents (VPs), Directors of business development, marketing, product development/innovation teams, and other key executives from manufacturers and distributors operating in the organ preservation market, as well as key opinion leaders.

The following is a breakdown of the primary respondents:

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

The research methodology used to estimate the size of the organ preservation market includes the following details.

The market sizing was undertaken from the global side.

Country-level Analysis: The size of the organ preservation market was obtained from the annual presentations of leading players and secondary data available in the public domain. Shares of products in the overall organ preservation market were obtained from secondary data and validated by primary participants to arrive at the total organ preservation market. Primary participants further validated the numbers.

Geographic Market Assessment (By Region & Country): The geographic assessment was done using the following approaches:

Approach 1: Geographic revenue contributions/splits of leading players in the market (wherever available) and respective growth trends

Approach 2: Geographic adoption trends for individual product segments by end users and growth prospects for each of the segments (assumptions and indicative estimates validated from primary interviews)

Industry experts contacted during primary research validated the assumptions and approaches at each point. Considering the limitations of data available from secondary research, revenue estimates for individual companies (for the overall organ preservation market and geographic market assessment) were ascertained based on a detailed analysis of their respective product offerings, geographic reach/strength (direct or through distributors or suppliers), and the shares of the leading players in a particular region or country.

Global Organ Preservation Market Size: Bottom-up Approach & Top-down Approach

Data Triangulation

The market was split into several segments and subsegments after arriving at the overall market size—using the market size estimation processes. Data triangulation and market breakdown procedures were employed to complete the overall market engineering process and determine each market segment's and subsegment's exact statistics. The data was triangulated by studying various factors and trends from both the demand and supply sides in the organ preservation market.

Market Definition

Organ preservation solutions are used to protect and preserve the viability of organs during organ transplantation. Utilizing distinct methodologies, organ preservation starts with the surgical removal of the donor organ and concludes with its placement in the recipient. Various solutions (such as the University of Wisconsin solution and Custodiol HTK) and techniques (such as static cold storage and hypothermic machine perfusion) are used to preserve organs.

Stakeholders

Association of Organ Procurement Organizations (AOPO)
American Transplant Congress (ATC)
United Network for Organ Sharing (UNOS)
Network & Alliance of Transplant Coordinators (NATCO)
Consortium for Organ Preservation in Europe (COPE)
European Society for Organ Transplantation (ESOT)
Asian Society of Transplantation (AST)
National Health Service (UK NHS)
International Registry on Organ Donation and Transplantation (IRODaT)
Global Observatory on Donation and Transplants (GODT)
National Institutes of Health (NIH)
World Health Organization (WHO)
Organisation for Economic Co-operation and Development (OECD)
Centers for Disease Control and Prevention (CDC)
Annual Reports/SEC Filings, Investor Presentations, and Press Releases of Key Players
White Papers, Journals/Magazines, and News Articles

Report Objectives

To define, describe, and forecast the organ preservation market based on solution, technique, organ type, end user, and region
To provide detailed information regarding the major factors influencing the growth of the market (drivers, restraints, opportunities, and challenges)
To strategically analyze micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall organ preservation market
To analyze market opportunities for stakeholders and provide details of the competitive landscape for market players
To estimate the market size and growth potential of the market segments with respect to six regions: North America, Europe, Asia Pacific, Latin America, the Middle East & Africa, and GCC Countries
To profile the key players operating in the organ preservation market and comprehensively analyze their revenue shares and core competencies2
To track and analyze competitive developments such as product launches & approvals, partnerships, agreements, collaborations, expansions, joint ventures, and acquisitions in the organ preservation market
To benchmark players in the market using the proprietary Competitive Leadership Mapping framework, which analyzes market players on various parameters within the broad categories of business strategy and product offering

Get the Full Organ Preservation Market Report

Full forecast, segment splits, and company analysis for all Organ Preservation Market.

Download Sample Pages Buy Report

REPORT COVERAGE

＋

Report Description
Market Overview
Market Dynamics
Related Ecosystem
Key Takeaways
Market Scope
Report Segmentation
Target Audience
Key Companies